Please assess the completion status of the following clinical trial:

Trial Title: PET CT With HX4 in Cervix Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion criteria~* Histologically confirmed cervix carcinoma (squamous cell carcinoma, adenocarcinoma or adenosquamous carcinoma)~* tumor stages FIGO IB - IVA~* WHO performance status 0 to 2~* Scheduled for primary curative radiotherapy (either or not combined with chemotherapy or hyperthermia)~* No previous surgery to the Cervix~* No previous radiation to the Cervix~* The patient is willing and capable to comply with study procedures~* 18 years or older~* Written informed consent before patient registration~Exclusion criteria~* Recent (\< 3 months) myocardial infarction~* Uncontrolled infectious disease~* Pregnant or breast feeding and/or not willing to take adequate contraceptive measures during the study

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- [18F] HX4 PET imaging (Type: EXPERIMENTAL): injection with \[18F\] HX4 and PET imaging at baseline and after 20 Gy radiotherapy

Based on this trial design, predict the completion outcome and termination type (if applicable).